5.15. summary evidence guidelines transurethral resection bladder, biopsies pathology report. summary evidenceletransurethral resection bladder tumour (turb) followed pathology investigation obtained specimen(s) essential step management nmibc.1the absence detrusor muscle specimen associated significantly higher risk residual disease tumour under-staging (with exception ta lg/g1 tumours).2ba second turb detect residual tumours tumour under-staging, increase recurrence-free survival, improve outcomes bcg treatment provide prognostic information.2photodynamic diagnosis shown improve detection bladder cancer, especially cis.1a recommendationsstrength ratingin patients suspected bladder cancer, perform transurethral resection bladder tumour (turb) followed pathology investigation obtained specimen(s) diagnostic procedure initial treatment step.strongperform turb systematically individual steps:bimanual palpation anaesthesia starting procedure end;insertion resectoscope, visual control inspection whole urethra;inspection whole urothelial lining bladder;biopsy prostatic urethra (if indicated);cold-cup bladder biopsies (if indicated);resection tumour;recording findings surgery report/record including visual impression grade/stage;precise description specimen(s) pathology evaluation.strongperformance individual stepsperform en-bloc resection resection fractions (exophytic part tumour, underlying bladder wall edges resection area).strongavoid cauterisation much possible turb avoid tissue deterioration.strongtake biopsies abnormal-looking urothelium.strongtake multiple biopsies (mapping biopsies trigone, bladder dome, right, left, anterior posterior bladder wall) perform photodynamic diagnosis (pdd) guided biopsies, case normal looking urothelium positive urine cytology.strongtake sample prostatic urethra positive urine cytology without evidence tumour bladder, abnormalities prostatic urethra visible (see section 5.11.2).strongtake sample biopsy prostatic urethra cases bladder neck tumour, suspicion bladder cis and/or t1 disease. sample taken initial procedure, performed time second resection, latter needed (see section 5.11.2).weakuse methods improve tumour visualisation (fluorescence cystoscopy, narrow-band imaging) turb, available.weakrefer specimens different biopsies resection fractions pathologist separately labelled containers. submit tumour base separately especially large multifocal tumours en-bloc resection feasible.weakthe turb record must describe tumour location, appearance, size multifocality, steps procedure, extent, macroscopic completeness resection well complications.strongin patients positive cytology, negative cystoscopy, exclude upper tract urothelial carcinoma, cis bladder (by mapping biopsies pdd-guided biopsies) tumour prostatic urethra (by prostatic urethra biopsy).strongperform second turb following situations:after incomplete initial turb, case doubt completeness turb;if detrusor muscle specimen initial resection, exception ta lg/g1 tumours primary cis;in t1 tumours.strongif indicated, perform second turb within 2â€“6 weeks initial resection. second turb include resection primary tumour site.weakrecord pathology results second turb reflects quality initial resection.weakinform pathologist prior treatments (intravesical therapy, radiotherapy, etc.).strongthe pathological report specify tumour location, tumour grade stage, lymphovascular invasion, subtypes urothelial carcinoma, presence cis detrusor muscle.strong